Please provide your email address to receive an email when new articles are posted on . A Bay Area neurotechnology firm has announced the commercial release of a novel artificial intelligence-based ...
From "Treatment of Convulsive Status Epilepticus in Children and Adults" Epilepsy Currents 16.1 January/February 2016. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders ...
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...
The choice of drugs for patients with status epilepticus that is refractory to treatment with benzodiazepines has not been thoroughly studied. In a randomized, blinded, adaptive trial, we compared the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback